<DOC>
	<DOCNO>NCT00745251</DOCNO>
	<brief_summary>The primary objective study evaluate safety efficacy VI-0521 compare placebo treatment obese adult obstructive sleep apnea ( OSA ) assess relative contribution weight loss parameter OSA subject .</brief_summary>
	<brief_title>A Study VI-0521 Treatment Obstructive Sleep Apnea / Hypopnea Syndrome Obese Adults</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Obese adult 30 65 year old ( inclusive ) ; Women childbearing potential must use adequate contraception ; BMI 30 40 kg/m2 ( inclusive ) ; Diagnosis OSA syndrome Apnea/Hypopnea Index ( AHI ) 15 great ; Unwilling unable comply CPAP treatment ; Known allergy hypersensitivity phentermine topiramate ; Sleep disorder OSA syndrome ; Women pregnant , breast feeding , intend become pregnant study ; Presence unstable angina heart failure correspond NYHA functional class III IV ; History myocardial infarction coronary revascularization within past year ; history stroke ; Presence clinically significant abnormality electrocardiogram ; Use prescription CNS stimulant ; History cholecystitis cholelithiasis unless treated cholecystectomy ; History glaucoma past present use medication treat increase intraocular pressure ; Weight gain loss great 5 kg , use lowcalorie diet , participation formal weight loss program ( investigational otherwise ) within past 3 month ; Previous bariatric surgery ; Shift worker subject circadian rhythm disorder ; Professional driver commercial pilot ; History nephrolithiasis ; More one lifetime episode major depression ; History bipolar disorder , obsessive compulsive disorder , borderline personality disorder , psychotic depression , schizophrenia , schizoaffective disorder , psychotic disorder ; history psychiatric hospitalization ; History seizure disorder ; concurrent use anticonvulsant drug ( assign study drug ) ;</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Sleep apnea ; obesity</keyword>
</DOC>